Altan Rentsendorj,Koen Raedschelders,Dieu‐Trang Fuchs,Julia Sheyn,Vineet Vaibhav,Rebecca A. Porritt,Haoshen Shi,Jargalsaikhan Dagvadorj,Juliana de Freitas Germano,Yosef Koronyo,Moshe Arditi,Keith L. Black,Bhakta Prasad Gaire,Jennifer E. Van Eyk,Maya Koronyo‐Hamaoui
Osteopontin (OPN; also known as SPP1), an immunomodulatory cytokine highly expressed in bone marrow-derived macrophages (BMMΦ), is known to regulate diverse cellular and molecular immune responses. We previously revealed that glatiramer acetate (GA) stimulation of BMMΦ upregulates OPN expression, promoting an anti-inflammatory, pro-healing phenotype, whereas OPN inhibition triggers a pro-inflammatory phenotype. However, the precise role of OPN in macrophage activation state is unknown.